Nugene International Stock Net Asset
| NUGN Stock | USD 0 0.0006 30.00% |
NuGene International fundamentals help investors to digest information that contributes to NuGene International's financial success or failures. It also enables traders to predict the movement of NuGene Pink Sheet. The fundamental analysis module provides a way to measure NuGene International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NuGene International pink sheet.
NuGene |
NuGene International Company Net Asset Analysis
NuGene International's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, NuGene International has a Net Asset of 0.0. This indicator is about the same for the Financial Services average (which is currently at 0.0) sector and about the same as Shell Companies (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
NuGene Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NuGene International's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of NuGene International could also be used in its relative valuation, which is a method of valuing NuGene International by comparing valuation metrics of similar companies.NuGene International is currently under evaluation in net asset category among its peers.
NuGene Fundamentals
| Return On Asset | -9.44 | |||
| Profit Margin | (0.11) % | |||
| Operating Margin | (0.11) % | |||
| Current Valuation | 14.83 M | |||
| Shares Outstanding | 219 M | |||
| Shares Owned By Insiders | 5.85 % | |||
| Price To Earning | (0.03) X | |||
| Price To Sales | 9.65 X | |||
| Revenue | 1.47 M | |||
| Gross Profit | (209.4 K) | |||
| EBITDA | (9.03 M) | |||
| Net Income | (75.19 K) | |||
| Cash And Equivalents | 118.34 K | |||
| Total Debt | 2.8 M | |||
| Debt To Equity | 1.05 % | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | 0.10 X | |||
| Cash Flow From Operations | (2 M) | |||
| Earnings Per Share | (0.29) X | |||
| Number Of Employees | 11 | |||
| Beta | 4.89 | |||
| Market Capitalization | 11.61 M | |||
| Total Asset | 585 K | |||
| Retained Earnings | (15.32 M) | |||
| Working Capital | (4.19 M) | |||
| Current Asset | 389 K | |||
| Current Liabilities | 4.58 M | |||
| Z Score | -89.9 |
About NuGene International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NuGene International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NuGene International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NuGene International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in NuGene Pink Sheet
NuGene International financial ratios help investors to determine whether NuGene Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NuGene with respect to the benefits of owning NuGene International security.